Paul H. Lee

Philadelphia Telemedicine Glaucoma Detection and Follow-up Study: Methods and Screening Results.

An integrated telemedicine screening intervention in primary care offices and Federally Qualified Health Centers detected high rate of suspicious optic nerves, ocular hypertension, and retinal pathology.

Large Disparities in Receipt of Glaucoma Care between Enrollees in Medicaid and Those with Commercial Health Insurance.

Irrespective of race/ethnicity, Medicaid recipients with OAG are receiving substantially less glaucoma testing compared with persons with commercial health insurance.

Application of the Sight Outcomes Research Collaborative Ophthalmology Data Repository for Triaging Patients With Glaucoma and Clinic Appointments During Pandemics Such as COVID-19.

A tool that considers the risk of underlying ophthalmic disease progression from delayed care receipt and the morbidity risk from COVID-19 exposure was developed and implemented, facilitating the triage of upcoming ophthalmic appointments.

Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs.

Eye care providers prescribe more brand medications by volume than any other provider group.

Cost-Utility Analysis of Glaucoma Medication Adherence.

At a conservative willingness to pay of $50 000/QALY, there is room to expand services to improve patient adherence.

The Impact of the Support, Educate, Empower Personalized Glaucoma Coaching Pilot Study on Glaucoma Medication Adherence.

The SEE program participants showed clinically meaningful, statistically significant improvement in glaucoma medication adherence.

Philadelphia Telemedicine Glaucoma Detection and Follow-up Study: Analysis of Unreadable Fundus Images.

Understanding the causes of unreadable fundus images will foster improvements in telemedicine techniques to optimize the predictive accuracy, efficiency, and cost in ophthalmology.

The Burden of Caring for and Treating Glaucoma: The Patient Perspective.

Participants expressed that the treatment of glaucoma creates a burden for patients that is distinct from the burden of the disease process itself and that this burden negatively affects their quality of life and can potentially cause vision-threatening issues with medication and appointment adherence.

Demographic, Clinical, and Psychosocial Predictors of Change in Medication Adherence in the Support, Educate, Empower Program.

Patient-level factors associated with relatively greater improvements in medication adherence through the SEE Program included lower income, fewer glaucoma medications, and increased GD.

Glaucoma Medication Adherence 1 Year after the Support, Educate, Empower Personalized Glaucoma Coaching Program.

Glaucoma medication adherence decreased significantly in the year after cessation of the SEE coaching program but remained significantly higher than baseline adherence. To maintain excellent long-term medication adherence, intermittent reinforcement sessions may be necessary.

Comparison of Medication Adherence Assessment Tools to Identify Glaucoma Medication Nonadherence.

The single-item question was the most accurate in predicting electronically monitored nonadherence among participants with poor self-reported adherence.

Establishing a Regional Glaucoma Physician Collaborative to Improve Quality of Care.

It is feasible to establish a regional glaucoma physician collaborative to improve standardization of care for patients with newly diagnosed POAG.

Development and Validation of the Low Vision Severely Constricted Peripheral Eyesight (LV-SCOPE) Questionnaire.

The LV-SCOPE Questionnaire provides a valid and reliable measure of vision-related functioning across 6 key domains relevant to individuals with severe PFL. Findings support the clinical utility of this psychometrically valid instrument.

User-centered Design of the eyeGuide: A Tailored Glaucoma Behavior Change Program.

User-centered design generated improvements in the eyeGuide that would not have been possible without patient input. Participants expressed satisfaction with the tailored content.

Assessing the Role of the Family/Support System Perspective in Patients With Glaucoma.

Support system individuals tend to be minimally involved in the patient's glaucoma status and care.

Why Patients With Glaucoma Lose Vision: The Patient Perspective.

These focus groups brought up many issues surrounding barriers to glaucoma treatment, perceived susceptibility to glaucoma, perceived benefits to treatment, and the emotional response to living with glaucoma.

Patterns of Glaucoma Medication Adherence over Four Years of Follow-Up.

For most patients who were newly prescribed glaucoma medications, adherence patterns observed in the first year of treatment reflect adherence patterns over the subsequent 3 years.

Subsequent Receipt of Interventions for Glaucoma Among a Nationwide Sample of Patients Who Underwent Laser Peripheral Iridotomy.

Most patients undergoing bilateral LPIs received no pre- or post-LPI glaucoma medication-class prescriptions and had no cataract or additional glaucoma surgery within 2 years after LPIs.

The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey.

Each of the 11 barriers was important to at least 30% of surveyed patients with poor adherence, with most identifying multiple barriers to adherence.